T. Mourez

发表

Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43

F. Freymuth, A. Vabret, J. Dina, 2006, Journal of Virological Methods.

Human Coronavirus NL 63 , France

J. Brouard, A. Vabret, J. Dina, 2005 .

Invasive meningoencephalitis as the first manifestation of hepatitis A

R. Lefaucheur, A. Roque-Afonso, V. Lemée, 2019, Journal of viral hepatitis.

Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction

F. Mouthon, J. Petitjean, F. Freymuth, 2001, Journal of Virological Methods.

UvA-DARE ( Digital Academic Repository ) Human coronavirus NL 63 ,

J. Brouard, A. Vabret, J. Dina, 2005 .

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

G. Duverlie, C. François, S. Castelain, 2017, Journal of Clinical Microbiology.

An Outbreak of Coronavirus OC43 Respiratory Infection in Normandy, France

J. Petitjean, F. Freymuth, A. Vabret, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.

C. Delaugerre, M. Vray, V. Lemée, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Non-M Variants of Human Immunodeficiency Virus Type 1

J. Plantier, F. Simon, T. Mourez, 2013, Clinical Microbiology Reviews.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.

J. Xie, Taisheng Li, Z. Qiu, 2006, Chinese medical journal.

Human Coronavirus NL63, France

L. van der Hoek, J. Petitjean, F. Freymuth, 2005, Emerging infectious diseases.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon

D. Rousset, J. Plantier, T. Mourez, 2017, Retrovirology.

Inter- and intra-variant genetic heterogeneity of human coronavirus OC43 strains in France.

S. van der Werf, J. Petitjean, F. Freymuth, 2006, The Journal of general virology.

Inter-and intra-variant genetic heterogeneity of human coronavirus OC 43 strains in France

S. Werf, J. Petitjean, F. Freymuth, 2006 .

Polyomaviruses KI and WU in Immunocompromised Patients with Respiratory Disease

G. Socié, P. Ribaud, A. Bergeron, 2009, Emerging Infectious Diseases.

Polyomaviruses KI and WU in immunocompromised patients with respiratory disease.

G. Socié, P. Ribaud, A. Bergeron, 2009, Emerging infectious diseases.

Detection of numerous HIV-1/MO recombinants in France

V. Lemée, M. Chaix, E. Gault, 2018, AIDS.

Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

C. Charpentier, D. Descamps, J. Plantier, 2018, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

P. André, G. Carcelain, A. Samri, 2017, EBioMedicine.

[Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure].

P. Plaisance, P. Sellier, G. Simoneau, 2012, Presse medicale.

Differential Regulation of Type I Interferon and Epidermal Growth Factor Pathways by a Human Respirovirus Virulence Factor

P. Vidalain, Y. Jacob, F. Tangy, 2009, PLoS pathogens.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors

C. Delaugerre, V. Lemée, M. Chaix, 2018, EBioMedicine.

First evidence of transmission of an HIV-1 M/O intergroup recombinant virus

R. Njouom, J. Plantier, T. Mourez, 2015, AIDS.

Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants

Jean-Christophe Plantier, V. Lemée, J. Plantier, 2016, Journal of acquired immune deficiency syndromes.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon

D. Rousset, J. Plantier, F. Simon, 2017, Retrovirology.

Algorithm-Based Prediction of HIV-1 Subtype D Coreceptor Use

J. Izopet, V. Ferré, S. Raymond, 2013, Journal of Clinical Microbiology.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Subtype D Coreceptor Use Algorithm-Based Prediction of HIV-1

J. Izopet, S. Raymond, J. Plantier, 2014 .

UvA-DARE ( Digital Academic Repository ) Human coronavirus NL 63 ,

J. Brouard, A. Vabret, J. Dina, 2005 .